Literature DB >> 7914720

Inhibition of IMP dehydrogenase by mycophenolic acid in Molt F4 human malignant lymphoblasts.

E H Stet1, R A De Abreu, J P Bökkerink, L H Lambooy, T M Vogels-Mentink, J J Keizer-Garritsen, F J Trijbels.   

Abstract

The effects of inhibition of inosine monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme in guanine nucleotide de novo synthesis, on cell growth, cell viability, endogenous nucleotide concentrations and concentrations of extracellular nucleosides and bases were studied in Molt F4 human malignant lymphoblasts. Mycophenolic acid (MPA) was used as a specific inhibitor of the enzyme activity. IMPDH activity was maximally inhibited with 0.5 microM MPA. After a 2 h exposure of the cells to 0.5 microM MPA, guanine nucleotides were depleted to approximately 50% of control values, whereas 5-phosphoribosyl-1-pyrophosphate levels increased to approximately 200%. Under these conditions, cytotoxicity became obvious after 24 h. Depletion of guanine nucleotides and cytotoxicity were prevented by addition of guanosine to MPA treatment. Daily supplements of guanosine were required to prevent MPA cytotoxicity during the entire incubation period of 72 h. We conclude that depletion of guanine nucleotides, induced by treatment with MPA, induces a severe and rapid cytotoxicity in Molt F4 cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7914720     DOI: 10.1177/000456329403100211

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  2 in total

1.  Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.

Authors:  Olga Millán; Mercè Brunet; Jaume Martorell; Felipe García; Elena Vidal; Isabel Rojo; Montserrat Plana; Teresa Gallart; Tomas Pumarola; Jose M Miró; Jose M Gatell
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Evaluation of cell viability dyes in antiviral assays with RNA viruses that exhibit different cytopathogenic properties.

Authors:  Donald F Smee; Brett L Hurst; W Joseph Evans; Nathan Clyde; Sean Wright; Christopher Peterson; Kie-Hoon Jung; Craig W Day
Journal:  J Virol Methods       Date:  2017-03-27       Impact factor: 2.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.